Symetryx Corporation

Symetryx Corporation is a medical technology company focused on the development and licensing of non-invasive diagnostic and monitoring solutions. The company's core technology centers on a non-invasive glucose monitoring system designed to alleviate the burden of finger-stick testing for patients with diabetes. Symetryx holds a robust portfolio of patents related to glucose sensing and has been actively involved in intellectual property litigation to protect its innovations in the continuous glucose monitoring (CGM) sector. Based in Toronto, the company aims to commercialize its sensor technology through partnerships and integration into next-generation wearable health devices.